tiprankstipranks
Trending News
More News >
Moleculin Biotech (MBRX)
NASDAQ:MBRX
US Market

Moleculin Biotech (MBRX) Ownership - Who Owns Moleculin Biotech?

Compare
1,911 Followers

Moleculin Biotech (MBRX) Ownership Overview

53.23%8.53%4.23%34.01%
53.23% Insiders
4.23% ETFs
34.01% Public Companies and
Individual Investors
The ownership structure of Moleculin Biotech (MBRX) stock is a mix of institutional, retail, and individual investors. , 53.23% is owned by Insiders, and 34.01% is owned by Public Companies and Individual Investors.
The ownership structure of Moleculin Biotech (MBRX) stock is a mix of institutional, retail, and individual investors. Approximately 12.77% of the company’s stock is owned by Institutional Investors, 53.23% is owned by Insiders, and 34.01% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value
Jun 23, 2025
xxxxxxxxxxxxx
$250000
Jun 23, 2025
xxxxxxxxxxxxx
$100000

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
765,356Insider37.04%3,444,102
303,189Insider14.67%1,364,351
88,824Institution4.30%399,708
87,486Institution4.23%393,687
87,486Institution4.23%393,687
16,771Insider0.81%75,470
14,660Insider0.71%65,970

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
88,824Institution4.30%399,708
87,486Institution4.23%393,687

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
236,207Institution11.43%64,414

FAQ

Who Owns Moleculin Biotech (MBRX)?
Currently, no data Available
What percentage of Moleculin Biotech (MBRX) stock is held by institutional investors?
Currently, no data Available
What percentage of Moleculin Biotech (MBRX) stock is held by retail investors?
According to the latest TipRanks data, approximately 34.01% of Moleculin Biotech (MBRX) stock is held by retail investors.
    Who owns the most shares of Moleculin Biotech (MBRX)?
    WALTER V KLEMP owns the most shares of Moleculin Biotech (MBRX).
      What is the significance of the ownership structure for a publicly traded company?
      The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.